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Emergence agitationAbstract Background: Emergence agitation (EA) is a common distressing problem in children
after sevoﬂurane general anesthesia. The aim of the present study was to test the efﬁcacy of keta-
mine in prevention of EA after sevoﬂurane general anesthesia in children undergoing magnetic reso-
nance imaging (MRI) scan. Also, we evaluated the safety and efﬁcacy of the face mask for
administration of sevoﬂurane anesthesia in children.
Methods: In this randomized study, 120 children aged 2–7 years (ASA I or II) of either sex sched-
uled for elective MRI scan under sevoﬂurane anesthesia were enrolled in the study protocol.
Patients were randomly allocated to one of 3 groups: saline group receiving normal saline
(n= 40), ketamine 0.25 group receiving 0.25 mg/kg of ketamine intravenously 10 min prior the
end of the procedure (n= 40), and ketamine 1.0 group receiving 1.0 mg/kg of ketamine intra-
venously before sevoﬂurane induction, (n= 40). Anesthesia was provided with sevoﬂurane in
100% oxygen. EA score, pausing of the scan, scan time, discharge time and any reported adverse
events were recorded.
Results: No signiﬁcant differences as regards age, weight, sex, or ASA score were found among the
studied groups. Children in ketamine 1.0 group reported signiﬁcant lower EA score in comparison
with ketamine 0.25 and saline groups (P< 0.05). Ketamine 0.25 group reported signiﬁcant lower
122 H.E.S. Moawad, T. El-DiastyEA score in comparison with saline group (P< 0.05). Children in ketamine 1.0 group reported sig-
niﬁcant lower incidence of pausing in comparison with ketamine 0.25 and saline groups (P< 0.05).
No signiﬁcant differences as regards nausea, vomiting, desaturation, scan and discharge times
among the studied groups (P> 0.05) were found.
Conclusion: Ketamine premedication was effective in reducing EA without delay in recovery and
signiﬁcantly reduced the incidence of pausing of MRI scan.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
The provision of anesthesia and sedation for children undergo-
ing procedures outside the operating room continues to evolve
[1]. MRI scan requires prolonged immobilization that can only
be provided by general anesthesia in pediatric patients [2]. EA
is a common problem in children after sevoﬂurane general
anesthesia [3]. The rapid emergence and recovery from sevoﬂu-
rane general anesthesia are associated with high incidence of
EA in children. However, the etiology of EA has not yet been
identiﬁed clearly. The predisposing factors are preschool age,
preoperative anxiety, lack of premedication and awakening
in a strange environment [4]. The incidence of EA had been
reported between 10% and 80% in different studies [5].
Sevoﬂurane is an inhalation anesthetic agent used frequently
to induce and maintain outpatient or pediatric anesthesia due
to its excellence in hemodynamic stability, less irritation of
the mucous membranes and low blood solubility, which causes
rapid induction and emergence from anesthesia [6]. The use of a
face mask that is ﬁrmly secured to the face of the child, brings
the concentration of sevoﬂurane needed to maintain general
anesthesia at a lower levels, and the spread of sevoﬂurane
throughout the environment is minimal [7]. Ketamine is an
effective sedative analgesic and it does not cause respiratory
depression at a small dose and does not affect heart rate and
blood pressure signiﬁcantly. It has strong preemptive analgesic
effects, suppresses the occurrence of EA in children and is use-
ful in sedating excited children before surgery [8].
In the present study, the aim was to test the efﬁcacy of keta-
mine in prevention of EA after sevoﬂurane general anesthesia
in children undergoing MRI scan. Ketamine was tested when
administered as a premedicant before induction of anesthesia
and when administered 10 min prior the end of the scan. Also,
we evaluated the safety and efﬁcacy of the face mask as a non-
invasive method for administration of sevoﬂurane general
anesthesia in children. Furthermore, pausing of the scan, respi-
ratory problems, scan time, discharge time and reported other
complications were evaluated.2. Materials and methods
This randomized double blind study was performed in Urol-
ogy and Nephrology Center, Mansoura University. The study
protocol was approved by local ethics committee. Between
May 2012 and September 2013, 120 children aged 2–7 years
(ASA I or II) of either sex scheduled for elective MRI scan
under sevoﬂurane general anesthesia through a face mask were
enrolled in the study protocol. Written informed consent was
obtained from at least one of the parents after explanation
of the procedure and purpose of the study. Past and currentmedical records were checked for associated medical disorders
and concomitant medication intake.
Exclusion criteria included patients with cardiopulmonary
diseases, head and neck congenital anomalies, airway prob-
lems and patients with cognitive or developmental disorders
were excluded from the study. Patients under treatment with
sedatives or anticonvulsants, emergency indications, and par-
ental refusal were also excluded from the study.
The patients were randomly allocated (by the use of sealed
envelopes and computer-generated random tables) to one of 3
groups: saline group (control group) administered normal sal-
ine solution (n= 40), ketamine 0.25 group administered
0.25 mg/kg of ketamine intravenously 10 min prior the end
of the procedure (n= 40) and ketamine 1.0 group adminis-
tered 1.0 mg/kg of ketamine intravenously before sevoﬂurane
induction (n= 40). All patients were premedicated with atro-
pine 0.01 mg/kg injected intramuscularly 30 min before induc-
tion of anesthesia.
On arrival at the MRI scan room, an intravenous line was
inserted and 10 ml/kg of normal saline solution was infused.
Patients were monitored with the standard monitors including
arterial blood pressure, electrocardiogram (ECG), pulse oxime-
ter (SPO2) and ETCO2. ETCO2 was monitored by the insertion
of the capnography tube tip line inside the ﬁtted face mask.
Patients in saline and ketamine 0.25 groups were adminis-
tered normal saline while patients in ketamine 1.0 group were
administered ketamine 1.0 mg/kg intravenously. All medica-
tions were administered by personnel who were not involved
in this study.
Induction of anesthesia to all patients was provided with
8% sevoﬂurane in 100% oxygen. Anesthesia was maintained
with sevoﬂurane 1–2% concentration in oxygen 5 L/min
through ﬁrmly secured ﬁtted pediatric face mask, while
patients breathe spontaneously. The head and neck of the chil-
dren were ﬁxed in extension position and suitable oral airway
was inserted to maintain airway patency. If the patient moved,
the concentration of sevoﬂurane was incrementally increased
by 0.5–1.0%. If apnea occurred, the concentration was
decreased by the same percent.
Ten minutes prior the end of the procedure, patients in sal-
ine and ketamine 1.0 groups were administered normal saline
and patients in ketamine 0.25 group were administered keta-
mine 0.25 mg/kg intravenously.
At the end of the procedure and when the radiologist
declared that the MRI procedure would end in 2 min, the
administration of sevoﬂurane was discontinued. After the
completion of the procedure, the face masks were removed,
and the children were allowed spontaneous recovery and trans-
ferred to the postanesthesia care unit (PACU). Arterial blood
pressure and SPO2 were monitored in the PACU. Parents were
called to the bedside at that time.
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- occurrence of respiratory adverse effects: apnea, laryn-
gospasm, desaturation (SPO2 below 92%),
- frequency of MRI scan pausing due to child movement or
monitoring failure,
- scan time: time taken for MRI study,
- discharge time: time from shifting to PACU until discharge,
- occurrence of postoperative nausea and vomiting and
- EA according to pediatric anesthesia emergence delirium
(PEAD) scale.
The quality of emergencewas assessed using PAEDbyphysi-
cian who was blinded to the group of the patients. The PAED
scale was designed to measure EA in children [9]. In this study
the PAED scale was used to measure EA based on ﬁve emer-
gence behaviors. Each scale item was scored from 0 to 4 and
the scores were summed to obtain a total score ranging from 0
to 20. We deﬁned a low PAED score (0–3) as a calm child mak-
ing eye contact, and a moderate PAED score (4–9) as a some-
what restless child aware of their surroundings and making
purposeful actions. A high PAED score (10–20) corresponded
to an inconsolable child who was crying, kicking, or screaming
(Table 1).
3. Statistical analysis
The sample size of 30 patients was calculated in each group
depending on the results from previous studies [10] assuming
a reduction in the incidence of sevoﬂurane agitation from
60% to 30% with the a-error level was ﬁxed at 0.05 and the
power was set at 90%. Some exclusion was expected, so the
number of the sample size was increased to 40 patients per
group. Data were analyzed using SPSS (Statistical Package
for Social Sciences) version 15. Qualitative data were presented
as number and percent. Comparison between groups was done
by Chi-Square test. Quantitative data were presented as
mean ± SD. One Way Anova was used to compare between
more than two groups. Post Hoc test (Fisher’s Least Sig-
niﬁcant Difference (LSD) test) was used for two groups’ com-
parison. P-value <0.05 was considered statistically signiﬁcant.
4. Results
One hundred twenty preschool children were enrolled in this
study. No signiﬁcant differences as regards age, weight, sex,Table 1 Pediatric anesthesia emergence delirium (PAED)
scale.
Score
The child makes eye contact with the caregiver 4 = not at all
The child’s actions are purposeful 3 = just a little
The child is aware of his/her surroundings 2 = quite a bit
1 = very much
0 = extremely
The child is restless 0 = not at all
The child is inconsolable 1 = just a little
2 = quite a bit
3 = very much
4 = extremelyand ASA score were found among the studied groups (Table 2).
Children in ketamine 1.0 group recorded signiﬁcant lower EA
score in comparison with ketamine 0.25 and saline groups
(P< 0.05). Ketamine 0.25 group recorded signiﬁcant lower
EA score in comparison with saline group (P< 0.05) (Table 3).
Children in ketamine 1.0 group recorded signiﬁcant lower inci-
dence of pausing and interruption ofMRI procedure in compar-
ison with ketamine 0.25 and saline groups (P< 0.05) where
only one child moves during the scanning procedure and neces-
sitates intervention by deepening the anesthesia while 6 children
in ketamine 0.25 group and 7 children in saline group recorded
pausing and interruption of MRI scanning (Table 3).
Children in the studied groups recorded no signiﬁcant dif-
ferences as regards scanning time and discharge time from
PACU (P> 0.05) (Table 4).
Children in the studied groups recorded no signiﬁcant differ-
ences as regards nausea, vomiting or desaturation (P> 0.05)
(Table 4). Where only one child in saline group developed nau-
sea but none of the children in ketamine 1.0 and ketamine 0.25
groups recorded nausea. Also two children in saline group suf-
fered vomiting in comparison with one child in each of ketamine
1.0 and ketamine 0.25 groups. Three children in saline group
developed desaturation in the postoperative period in compar-
ison with two children in ketamine 0.25 group and one child in
ketamine 1.0 group (Table 5). No children in the studied groups
had other complications such as arrhythmia, hypotension or
apnea. None of the children in the studied groups needed inva-
sive airway and mechanical ventilation.
5. Discussion
In this study the preventive effect of ketamine 1.0 mg/kg
administered as a premedicant was compared with ketamine
0.25 mg/kg administered 10 min prior the end of MRI scan-
ning procedure in children undergoing MRI scan under
sevoﬂurane general anesthesia through ﬁrmly secured ﬁtted
pediatric face mask with spontaneous breathing. This study
shows that the incidence of EA measured by PAED scale
was signiﬁcantly lower in ketamine 1.0 group in comparison
with both ketamine 0.25 and saline groups (P< 0.05) and
the incidence of EA was signiﬁcantly lower in ketamine 0.25
group in comparison with the saline group (P< 0.05) without
delay in the recovery or discharge from PACU.
EA is characterized by self-limiting aggressive agitation
developed in the early phase of awakening from general anes-
thesia. EA carries the risk of children injuring themselves and
their healthcare providers causing delay of discharge from the
PACU [4,8].
Sevoﬂurane is an inhalational anesthetic that is used widely
in pediatric and outpatient anesthesia due to its hemodynamic
stability and low blood solubility, which allows rapid induction
and emergence from general anesthesia, with excellent control
of the depth of anesthesia [11].
In this study the environmental sevoﬂurane pollution in the
scanning roomwasminimized by ﬁrmly secured ﬁtted facemask
to the face of the child, thus keeping the needed sevoﬂurane con-
centration to maintain general anesthesia at the lowest levels.
However, the use of sevoﬂurane alone is associated with a
higher incidence of EA in children due to its low blood solubi-
lity and consequently rapid removal of residual sevoﬂurane
anesthetic [12].








Age 4.58 ± 1.36 4.33 ± 1.42 4.23 ± 1.48 0.526
Weight 17.08 ± 2.71 16.53 ± 2.91 16.53 ± 3.03 0.617
Sex
Male 24 (60%) 22 (55%) 22 (55%) 0.873
Female 16 (40%) 18 (45%) 18 (45%)
ASA
I 18 (45%) 12 (30%) 15(38%) 0.383
II 22 (55%) 28 (70%) 25 (62%)
Table 3 Emergence agitation score and pausing of MRI scanning in the studied groups, values are presented as mean ± SD or








EA score 12.00 ± 1.59* 4.63 ± 0.95 2.50 ± 0.99 <0.001*
Pausing 7 (17.5%) 6 (15%) 1 (2.5%)* 0.024*
* Signiﬁcant (P< 0.05) in comparison with the other groups.
 Signiﬁcant (P< 0.05) in comparison with the other groups.









Nausea 1 (2.5%) 0 (0%) 0 (0%) 0.827
Vomiting 2 (5%) 1 (2.5%) 1 (2.5%) 0.761
Desaturation 3 (7.5%) 2 (5%) 1 (2.5%) 0.775








Scanning time (minutes) 35.93 ± 2.40 35.28 ± 2.80 34.31 ± 3.58 0.742
Discharge time (minutes) 22.28 ± 1.52 21.88 ± 1.68 21.35 ± 1.82 0.159
n= number of patients.
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incidence of EA by ketamine [2,10], nalbuphine [2], propofol
[13], fentanyl [14], melatonin [15], ketofol [16], dextromethor-
phan [17], etc., but the etiology and preventive treatments of
EA remain unclear [11].
Ketamine suppresses the occurrence of EA in children [18].
It has strong analgesic effect at less than anesthesia-inducting
doses, and does not cause respiratory depression at a small
dose less than 1 mg/kg, with insigniﬁcant effects on the heart
rate and blood pressure [19].
According to Kwak et al. [20] the incidence of EA was
decreased without delay in the recovery time with intravenous
injection of ketamine 1.0 mg/kg, administered after sevoﬂu-
rane induction in young children undergoing tonsillectomy
under sevoﬂurane general anesthesia.
In a study done by Lee et al. [11], the incidence of EA was
decreased without any particular side-effects or delay in therecovery time after intravenous administration of ketamine
0.25 mg/kg or 0.5 mg/kg 10 min prior the end of surgery.
Dalens et al. [2] reported that the administration of intra-
venous ketamine 0.25 mg/kg at the end of the scanning proce-
dure prevented EA in children undergoing MRI under
sevoﬂurane general anesthesia.
Limited number of studies investigated sevoﬂurane general
anesthesia for MRI scan using face mask with spontaneous
breathing [7,21].
In this study anesthesia was maintained under ﬁrmly
secured ﬁtted pediatric face mask sevoﬂurane in a titrating
concentration of 1–2% and the use of ketamine 1 mg/kg as a
premedicant not only decreased sevoﬂurane concentration
but also decreased signiﬁcantly the incidence of EA and paus-
ing of the scan (P< 0.05).
Kim et al. [22] recommended sevoﬂurane insufﬂation tech-
nique using nasal cannula as one of the sedation options in
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only for nonpainful radiologic examination.
Ogurlu et al. [7] reported that sevoﬂurane could be reliably
administered with a face mask at different concentrations. They
also noted that with the reduction of sevoﬂurane concentration
(1.5–1.25–1%) inadequate anesthesia did not come about. Ade-
quate anesthesia in children at low sevoﬂurane concentrations
was made feasible in that study by premedication with midazo-
lambefore theMRI scan. Thus, we hypothesized that utilization
of ketamine as premedicant prior the scan will reduce the
required sevoﬂurane concentration in addition to reduction of
EA and pausing of the scan.
In this study, ketamine 0.25 mg/kg administered 10 min pri-
or the end of theMRI scanning resulted in signiﬁcant reduction
in the incidence of EA. However, this did not result in reduction
of the incidence of scan pausing as the anesthesia was main-
tained throughout the procedure by sevoﬂurane only. The inci-
dence of scan pausing in this group was similar to the saline
group.
With regard to scanning times, recovery times, hemody-
namic and respiratory parameters and complications, no sig-
niﬁcant differences were observed among the studied groups.
Limitation of this study, premedication with sedatives or
anxiolytics were not given to saline or ketamine 0.25 groups
as preoperative anxiety may affect EA.
6. Conclusion
Ketamine 1.0 mg/kg administered intravenously as a premedi-
cant and ketamine 0.25 mg/kg administered intravenously
10 min prior the end of MRI scan were effective in reducing
the incidence of EA without delay in the recovery time or dis-
charge from PACU with insigniﬁcant complications. Pre-scan
ketamine 1.0 mg/kg signiﬁcantly reduced the incidence of
pausing of MRI scan. Administration of sevoﬂurane through
face mask with spontaneous breathing provides safe and ade-
quate anesthesia for children undergoing MRI scan.
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